Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Auto-pended bot liver ultrasound order.
- Who it may be relevant to
- Registry conditions: Hepatocellular Carcinoma, Cirrhosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Overview
The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Interventions
- Other Auto-pended bot liver ultrasound order
This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.
Primary outcome measures
- Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound [Time frame: Day 1]
Secondary outcome measures (2)
- Percentage of Participants with Completed Liver Ultrasound Imaging [Time frame: Day 1]
- HCC Diagnosis Rate from Completed Liver Ultrasound Imaging [Time frame: Day 1]
Eligibility criteria
Inclusion criteria
- cirrhosis diagnosis,
- 6 months or more after since most recent imaging.
Exclusion criteria
- previous liver transplant,
- HCC diagnosis,
- receiving hospice care,
- completed external imaging in the past 6 months.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- NYU Langone Health — New York
Identifiers
NCT: NCT06624189 · QI-Active Choice CDS